Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 444

1.

Long-term follow-up of patients requiring intravenous amiodarone to suppress hemodynamically destabilizing ventricular arrhythmias.

Fogel RI, Herre JM, Kopelman HA, Kowey PR, Trohman RG, Fineberg N, Prystowsky EN.

Am Heart J. 2000 Apr;139(4):690-5.

PMID:
10740153
2.
3.
4.

Electrophysiologic testing in patients who respond acutely to intravenous amiodarone for incessant ventricular tachyarrhythmias.

Kowey PR, Marinchak RA, Rials SJ, Rubin AM, Smith L.

Am Heart J. 1993 Jun;125(6):1628-32.

PMID:
8498304
8.

Dose-ranging study of intravenous amiodarone in patients with life-threatening ventricular tachyarrhythmias. The Intravenous Amiodarone Multicenter Investigators Group.

Scheinman MM, Levine JH, Cannom DS, Friehling T, Kopelman HA, Chilson DA, Platia EV, Wilber DJ, Kowey PR.

Circulation. 1995 Dec 1;92(11):3264-72.

9.

Idiopathic ventricular fibrillation: clinical, electrophysiologic characteristics and long-term outcomes.

Tsai CF, Chen SA, Tai CT, Chiang CE, Ding YA, Chang MS.

Int J Cardiol. 1998 Mar 13;64(1):47-55.

PMID:
9579816
10.
11.

Intravenous amiodarone for recurrent sustained hypotensive ventricular tachyarrhythmias. Intravenous Amiodarone Multicenter Trial Group.

Levine JH, Massumi A, Scheinman MM, Winkle RA, Platia EV, Chilson DA, Gomes A, Woosley RL.

J Am Coll Cardiol. 1996 Jan;27(1):67-75.

12.

[Pharmacologic therapy of ventricular tachyarrhythmias: value of class III anti-arrhythmia drugs].

Haverkamp W, Borggrefe M, Block M, Böcker D, Breithardt G.

Z Kardiol. 1996;85 Suppl 6:97-106. Review. German.

PMID:
9064989
13.

Clinical usefulness of electrophysiologic testing in patients with ventricular tachycardia and chronic chagasic cardiomyopathy treated with amiodarone or sotalol.

Leite LR, Fenelon G, Simoes A Jr, Silva GG, Friedman PA, de Paola AA.

J Cardiovasc Electrophysiol. 2003 Jun;14(6):567-73.

PMID:
12875414
14.
15.

Suppression of sustained ventricular tachyarrhythmias: a comparison of d,l-sotalol with no antiarrhythmic drug treatment.

Kühlkamp V, Mewis C, Mermi J, Bosch RF, Seipel L.

J Am Coll Cardiol. 1999 Jan;33(1):46-52.

16.

Amiodarone: clinical trials.

Naccarelli GV, Wolbrette DL, Patel HM, Luck JC.

Curr Opin Cardiol. 2000 Jan;15(1):64-72. Review.

PMID:
10666663
18.

In-hospital versus out-of-hospital presentation of life-threatening ventricular arrhythmias predicts survival: results from the AVID Registry. Antiarrhythmics Versus Implantable Defibrillators.

Epstein AE, Powell J, Yao Q, Ocampo C, Lancaster S, Rosenberg Y, Cannom DS, Herre JM, Greene HL.

J Am Coll Cardiol. 1999 Oct;34(4):1111-6.

19.

Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone.

Connolly SJ, Gent M, Roberts RS, Dorian P, Roy D, Sheldon RS, Mitchell LB, Green MS, Klein GJ, O'Brien B.

Circulation. 2000 Mar 21;101(11):1297-302.

20.

Appropriate ICD therapy in patients with idiopathic dilated cardiomyopathy: long term follow-up.

Karaoguz R, Maydanozcu S, Altun T, Güldal M, Akyürek O, Erol C.

Int Heart J. 2006 Sep;47(5):763-73.

Supplemental Content

Support Center